Bortezomib Viatris 3.5 mg inj. sol. (pwdr.) s.c./i.v. vial Belgique - anglais - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bortezomib viatris 3.5 mg inj. sol. (pwdr.) s.c./i.v. vial

viatris gx bv-srl - bortezomib mannitol boronic ester - eq. bortezomib 3,5 mg - powder for solution for injection - 3,5 mg - bortezomib mannitol boronic ester - bortezomib

Bortezomib Sandoz 3,5 mg inj. sol. (pwdr.) s.c./i.v. vial Belgique - anglais - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bortezomib sandoz 3,5 mg inj. sol. (pwdr.) s.c./i.v. vial

sandoz sa-nv - bortezomib mannitol boronic ester - eq. bortezomib 3,5 mg - powder for solution for injection - 3,5 mg - bortezomib mannitol boronic ester - bortezomib

Bortezomib Sandoz 1 mg inj. sol. (pwdr.) i.v. vial Belgique - anglais - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bortezomib sandoz 1 mg inj. sol. (pwdr.) i.v. vial

sandoz sa-nv - bortezomib mannitol boronic ester - eq. bortezomib 1 mg - powder for solution for injection - 1 mg - bortezomib mannitol boronic ester - bortezomib

Bortezomib Teva 1 mg inj. sol. (pwdr.) i.v. vial Belgique - anglais - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bortezomib teva 1 mg inj. sol. (pwdr.) i.v. vial

teva pharma belgium sa-nv - bortezomib mannitol boronic ester - eq. bortezomib 1 mg - powder for solution for injection - 1 mg - bortezomib mannitol boronic ester - bortezomib

Bortezomib Teva 3,5 mg inj. sol. (pwdr.) i.v./s.c. vial Belgique - anglais - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bortezomib teva 3,5 mg inj. sol. (pwdr.) i.v./s.c. vial

teva pharma belgium sa-nv - bortezomib mannitol boronic ester - eq. bortezomib 3,5 mg - powder for solution for injection - 3,5 mg - bortezomib mannitol boronic ester - bortezomib

BORTEZOMIB TEVA  1 MG Israël - anglais - Ministry of Health

bortezomib teva 1 mg

abic marketing ltd, israel - bortezomib - powder for solution for injection - bortezomib 1 mg - bortezomib - bortezomib teva is indicated for the treatment of patients with multiple myeloma. bortezomib teva is indicated for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy. bortezomib teva in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma who are unsuitable for haematopoietic stem cell transplantation

BORTEZOMIB INOVAMED 3.5 MG Israël - anglais - Ministry of Health

bortezomib inovamed 3.5 mg

inovamed ltd - bortezomib - powder for solution for injection - bortezomib 3.5 mg - bortezomib - bortezomib inovamed is indicated for the treatment of patients with multiple myeloma.bortezomib inovamed is indicated for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy. bortezomib inovamed in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma who are unsuitable for haematopoietic stem cell transplantation.

BORTEZOMIB TEVA  2.5 MG Israël - anglais - Ministry of Health

bortezomib teva 2.5 mg

abic marketing ltd, israel - bortezomib - powder for solution for injection - bortezomib 2.5 mg - bortezomib - bortezomib teva is indicated for the treatment of patients with multiple myeloma. bortezomib teva is indicated for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy. bortezomib teva in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma who are unsuitable for haematopoietic stem cell transplantation

Bortezomib Sandoz 2,5 mg inj. sol. (pwdr.) i.v./s.c. vial Belgique - anglais - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bortezomib sandoz 2,5 mg inj. sol. (pwdr.) i.v./s.c. vial

sandoz sa-nv - bortezomib mannitol boronic ester - eq. bortezomib 2,5 mg - powder for solution for injection - 2,5 mg - bortezomib mannitol boronic ester - bortezomib

Bortezomib Waverley Pharma Europe 1 mg inj. sol. (pwdr.) i.v. vial Belgique - anglais - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bortezomib waverley pharma europe 1 mg inj. sol. (pwdr.) i.v. vial

waverley pharma europe ltd. - bortezomib mannitol boronic ester - eq. bortezomib 1 mg - powder for solution for injection - 1 mg - bortezomib mannitol boronic ester - bortezomib